CVS HEALTH Corp (CVS): who owns it and who trades it
As of Nov 16, 2026, CVS insiders reported 8 open-market sales worth $324M and 1 purchase worth $2M in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Larry Robbins (Director), with $317M. 11 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling CVS Health
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns CVS
2,053 funds and institutions reported CVS shares worth $117B at the end of Q2 2026, about 89% of the company. The largest holder is BlackRock, Inc. with 9.7%.
Funds and institutions (13F) 89%Everyone else 11%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 123.22M | 9.66% | $12.7B | -2% |
| Vanguard Capital Management LLC | 83.32M | 6.53% | $8.6B | +1% |
| Capital World Investors | 74.95M | 5.87% | $7.8B | -3% |
| State Street Corp | 60.28M | 4.72% | $6.2B | +2% |
| Dodge & Cox | 50.01M | 3.92% | $5.2B | -3% |
| Wellington Management Group LLP | 33.80M | 2.65% | $3.5B | +50% |
| Geode Capital Management, LLC | 29.90M | 2.34% | $3.1B | +1% |
| FMR LLC (Fidelity) | 28.92M | 2.27% | $3B | -7% |
| Vanguard Portfolio Management LLC | 26.64M | 2.09% | $2.8B | +2% |
| Capital Research Global Investors | 24.33M | 1.91% | $2.5B | +22% |
| T. Rowe Price Associates | 24.20M | 1.90% | $2.5B | +2% |
| Bank of America Corp | 23.19M | 1.82% | $2.4B | +148% |
| JPMorgan Chase & Co | 22.11M | 1.73% | $2.3B | – |
| Invesco Ltd. | 20.60M | 1.61% | $2.1B | -18% |
| Morgan Stanley | 18.61M | 1.46% | $1.9B | +4% |
| Norges Bank | 18.04M | 1.41% | $1.9B | – |
| Capital International Investors | 15.39M | 1.21% | $1.6B | No change |
| Goldman Sachs Group Inc | 13.41M | 1.05% | $1.4B | +6% |
| Charles Schwab Investment Management Inc | 13.26M | 1.04% | $1.4B | -3% |
| Davis Selected Advisers | 11.87M | 0.93% | $1.2B | -3% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, CVS insiders reported $2M of open-market purchases and $324M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Prem S Shah | Vice president | Purchase | 23,855 | $83.89 | $2M | Form 4 |
| May 21, 2026 | Larry Robbins | Director | Sale | 370,462 | $93.45 | $34.6M | Form 4 |
| May 20, 2026 | Larry Robbins | Director | Sale | 66,881 | $95.67 | $6.4M | Form 4 |
| May 20, 2026 | Larry Robbins | Director | Sale | 800 | $96.28 | $77K | Form 4 |
| May 20, 2026 | Larry Robbins | Director | Sale | 797,628 | $93.48 | $74.6M | Form 4 |
| May 20, 2026 | Larry Robbins | Director | Sale | 152,691 | $94.81 | $14.5M | Form 4 |
| May 19, 2026 | Larry Robbins | Director | Sale | 1.98M | $94.45 | $187M | Form 4 |
| May 19, 2026 | Larry Robbins | Director | Sale | 151 | $95.18 | $14.4K | Form 4 |
| May 8, 2026 | Tilak Mandadi | Vice president | Sale | 69,551 | $89.58 | $6.2M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Larry Robbins | Director | – | $317M | May 21, 2026 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | – | $6.2M | May 8, 2026 |
| Prem S Shah | EVP and Group President | $2M | – | Nov 6, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
CVS short interest
Low short interest. 1.4% of CVS shares are sold short: about 1 share in 72. Over the last 12 reports the number of shares short went down 8%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 17.88M CVS shares were sold short, 1.4% of the shares outstanding, up 10.4% from the report before. At the average daily volume of 6.42M shares, buying them all back would take about 2.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 17.88M | 1.40% | +10% | 6.42M | 2.8 |
| Oct 15, 2026 | 16.19M | 1.27% | -2% | 10.33M | 1.6 |
| Sep 30, 2026 | 16.47M | 1.29% | +2% | 9.94M | 1.7 |
| Sep 15, 2026 | 16.12M | 1.26% | -11% | 5.13M | 3.1 |
| Aug 31, 2026 | 18.11M | 1.42% | +8% | 6.46M | 2.8 |
| Aug 14, 2026 | 16.82M | 1.32% | -10% | 9.34M | 1.8 |
| Jul 31, 2026 | 18.68M | 1.46% | -4% | 7.74M | 2.4 |
| Jul 15, 2026 | 19.52M | 1.53% | -2% | 7.19M | 2.7 |
| Jun 30, 2026 | 19.94M | 1.56% | -14% | 8.65M | 2.3 |
| Jun 15, 2026 | 23.19M | 1.82% | +31% | 8.56M | 2.7 |
| May 29, 2026 | 17.76M | 1.39% | -9% | 7.45M | 2.4 |
| May 15, 2026 | 19.52M | 1.53% | +10% | 9.89M | 2.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded CVS
Since Nov 17, 2024, 11 members of Congress reported 5 purchases and 10 sales of CVS. The latest was a purchase by Alan Armstrong on Mar 27, 2026, reported Jul 21, 2026.
Purchases 5Sales 10
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Jan 29, 2026 | John Boozman (R-AR) | Purchase | $1K–$15K | Joint | Feb 15, 2026 | Report |
| Nov 21, 2025 | Dwight Evans (D-PA) | Sale | $1K–$15K | Self | Dec 19, 2025 | Report |
| Oct 31, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Oct 30, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Oct 30, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Sep 23, 2025 | Val T. Hoyle (D-OR) | Sale | $1K–$15K | Spouse | Oct 10, 2025 | Report |
| Aug 8, 2025 | Adam Smith (D-WA) | Sale | $1K–$15K | Self | Aug 8, 2025 | Report |
| May 15, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | May 31, 2025 | Report |
| May 12, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Jun 22, 2025 | Report |
| Apr 1, 2025 | Julie Johnson (D-TX) | Sale | $1K–$15K | Joint | May 14, 2025 | Report |
| Feb 25, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | Mar 27, 2025 | Report |
| Jan 31, 2025 | J. French Hill (R-AR) | Sale | $15K–$50K | Self | Feb 4, 2025 | Report |
| Jan 24, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Feb 11, 2025 | Report |
| Jan 15, 2025 | Julie Johnson (D-TX) | Partial sale | $1K–$15K | Joint | Feb 12, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
CVS Health company events
CVS Health filed 10 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026AnnouncementShared information with investors. Filing
- Nov 4, 2026ResultsReleased financial results. Filing
- Aug 17, 2026LeadershipLarry M. Robbins notified the Board of Directors of CVS Health Corporation of his resignation from the Board, effective immediately. Filing
- Aug 5, 2026ResultsReleased financial results. Filing
- May 18, 2026LeadershipCVS Health Corporation held its 2026 Annual Meeting of Stockholders. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Mar 19, 2026LeadershipThe Board of Directors of CVS Health Corporation elected John E. Gallina to serve on the Board, effective March 19, 2026. Filing
- Feb 10, 2026ResultsReleased financial results. Filing
- Dec 9, 2025AnnouncementShared information with investors. Filing
- Nov 20, 2025AnnouncementThe Board of Directors of CVS Health Corporation appointed J. David Joyner, President and Chief Executive Officer of the Company, to the additional role of Chair of the Board, effective January 1, 2026. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
CVS Health financials
Famous investors that hold CVS
11 of the 50 well-known investors we track reported holding CVS in their latest 13F filing. The largest position is Richard Pzena's, worth $882M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Richard Pzena · Pzena Investment Management | Q3 2026 | 10.30M | $882M | 2.6% | -13% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 2.72M | $233M | 0.3% | +518% |
| Prem Watsa · Fairfax Financial Holdings | Q3 2026 | 2.71M | $232M | 8.8% | No change |
| Israel Englander · Millennium Management | Q3 2026 | 1.50M | $128M | 0.1% | -31% |
| Larry Robbins · Glenview Capital Management | Q3 2026 | 1.28M | $110M | 1.9% | -73% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 815,797 | $69.9M | 0.0% | -83% |
| Jeremy Grantham · GMO | Q3 2026 | 545,737 | $46.8M | 0.1% | +1% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 378,152 | $32.4M | 0.1% | -14% |
| Bill Nygren · Harris Associates (Oakmark) | Q3 2026 | 260,727 | $22.3M | 0.0% | -22% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 97,886 | $8.4M | 0.0% | +6% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 19,246 | $1.6M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about CVS HEALTH Corp (CVS) stock
Who owns the most CVS stock?
The largest reported owner of CVS HEALTH Corp (CVS) is BlackRock, Inc., with 9.7% of the company. In total, 2,053 funds and institutions reported holding CVS at the end of Q2 2026, together about 89% of the shares. See the largest owners.
Are CVS insiders buying or selling?
In the last 12 months, CVS insiders reported 1 open-market purchase worth $2M and 8 sales worth $324M. The latest trade was on Nov 6, 2026. See every trade.
What is the short interest in CVS?
As of Oct 30, 2026, 17.88M CVS shares were sold short, 1.4% of the shares outstanding, up 10.4% from the report before. At the average daily volume of 6.42M shares, buying them all back would take about 2.8 trading days (days to cover). See the history.
Have members of Congress traded CVS?
Yes. 11 members of Congress reported 5 purchases and 10 sales of CVS since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.
Which famous investors hold CVS?
11 of the 50 well-known investors we track reported CVS in their latest 13F filing, including Richard Pzena, Jim Simons, Prem Watsa. The largest position is worth $882M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.